Publish date: May 31, 2019 By Kari Oakes Clinical Neurology News FROM AN FDA PUBLIC HEARING The Food and Drug Administration held its first-ever public hearing about products containing cannabis or cannabis-derived compounds – and it got an earful. Hearing from over 100 individuals, the all-staff FDA panel was asked repeatedly to take the lead in bringing order […]
Publish date: April 28, 2019By M. Alexander Otto REPORTING FROM PAS 2019 BALTIMORE – Marijuana is a not a good idea during pregnancy, and it’s an even worse idea when women are being treated for opioid addiction, according to an investigation from East Tennessee State University, Mountain Home. Marijuana use may become more common as legalization rolls out […]
Concern raised about drug’s abuse potential Publish date: May 21, 2019 By Jim Kling REPORTING FROM APA 2019 SAN FRANCISCO – In treatment-resistant depression, a switch to a new antidepressant combined with inhaled esketamine (Spravato) led to better symptom improvement than did a switch to a new antidepressant plus placebo, results from a new trial show. The […]
Repetitive transcranial magnetic stimulation (rTMS) showed efficacy in patients with major depressive disorder (MDD) and comorbid anxiety, according to results from a study published in the Journal of Affective Disorders. Researchers conducted a single-site, nonrandomized, comparison study of 248 patients who received rTMS therapy for treatment-resistant MDD. Among those included, 172 participants had a minimum of 1 comorbid […]
The colorful painting of a bass player that hangs in the office of Robert Pollack, MD, is typical of Cori Scheft’s work. It’s a vivid and vibrant collage of brightly dyed newspaper clippings, fabrics and strips of sheet music that believe one simple fact: Cori has been suffering from a Brain Disease know as Depression. […]
Repetitive transcranial magnetic stimulation (rTMS), given at high or low frequency, effectively reduces motor symptoms in Parkinson’s disease patients, but the effects of high-frequency rTMS are superior and last longer, a clinical trial shows. Investigators also found that the treatment is more effective in patients with akinetic-rigid Parkinson’s — those with slow movements and rigidity — than in patients with […]
Editor’s Note: This article by Patricia Kime originally appeared on Military.com, a leading source of news for the military and veteran community. The newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will soon be available to veterans treated within the Department of Veterans Affairs. In a […]
The use of higher-than-recommended doses of zolpidem was commonly seen in women not previously treated with the drug, according to results from a study published in the Journal of Clinical Psychiatry. Researchers conducted a retrospective cohort study of 139,525 people who had never been treated with zolpidem and were prescribed the drug from January 1, 2013, […]
Mild depression was a long-term independent predictor of death in patients after acute myocardial infarction (AMI), per cohort study data published in Heart, Lung and Circulation. Investigators conducted a 25-year follow-up of men who were recruited after AMI to participate in a randomized controlled trial in the 1980s. The initial trial investigated the impact of high intensity exercise […]
I believe in working together to find the right treatment options. Taking into account your preferences, culture, beliefs, and attitudes as well as considering the latest advances and research in mental health care. Using my expertise in psychopharmacology and psychotherapy, we can tailor a treatment that works for you, one that will help you get better, to make the most of your life, and to feel good again.